TLC News
Archived Headlines
- How do listed companies perform with a US IPO? 04/19/18
- Pain biotech Taiwan Liposome Co. sets terms for $35 million IPO 04/16/18
- US IPO Week Ahead: 1 biotech expected in the week ahead, 4 deals could launch starting Monday 03/02/18
- US IPO Week Ahead: 1 SPAC expected this week, and 9 IPOs to look for in March 02/23/18
- US IPO Weekly Recap: IPO market recovers in a week with 4 small deals 02/16/18
See more
US IPO Weekly Recap: 2 foreign IPOs price during short Thanksgiving week
Two companies completed US IPOs this past week: Chinese auto play TuanChe (TC) and biotech Taiwan Lipsosome Company (TLC). Both deals raised less than $25 million, with over half coming from investors that had been disclosed...read more
Taiwan Liposome Company prices downsized US offering at $5.80
Taiwan Liposome Company (TLC), which is developing lipid formulations of approved drugs for pain and eye disease, raised $22 million by offering 3.75 million ADSs at $5.80. Listed on the Taipei Exchange (TPEx: 4152), TLC closed Tuesday in Taiwan at an...read more
Pain biotech Taiwan Liposome decreases proposed US IPO deal size and discloses updated financials
Taiwan Liposome, which is developing lipid formulations of approved drugs for pain and eye disease, lowered the proposed deal size for its upcoming IPO and disclosed updated financials for the nine months ended September 30, 2018 on Thursday. The Taipei...read more
US IPO Week Ahead: DocuSign leads tech IPO surge in 6-deal week
Six companies are scheduled to raise a combined $1.3 billion in the week ahead. Digital signature unicorn DocuSign (DOCU) headlines the week, combining high sales, fast growth and positive cash flow. It, Ceridian HCM (CDAY)...read more